BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31075771)

  • 1. The value of visible 5-ALA fluorescence and quantitative protoporphyrin IX analysis for improved surgery of suspected low-grade gliomas.
    Widhalm G; Olson J; Weller J; Bravo J; Han SJ; Phillips J; Hervey-Jumper SL; Chang SM; Roberts DW; Berger MS
    J Neurosurg; 2019 May; ():1-10. PubMed ID: 31075771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
    Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
    J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma.
    Kaneko S; Suero Molina E; Sporns P; Schipmann S; Black D; Stummer W
    J Neurosurg; 2022 Jan; 136(1):9-15. PubMed ID: 34144512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of 5-ALA in Low-Grade Gliomas and the Influence of Antiepileptic Drugs on Intraoperative Fluorescence.
    Goryaynov SA; Widhalm G; Goldberg MF; Chelushkin D; Spallone A; Chernyshov KA; Ryzhova M; Pavlova G; Revischin A; Shishkina L; Jukov V; Savelieva T; Victor L; Potapov A
    Front Oncol; 2019; 9():423. PubMed ID: 31192128
    [No Abstract]   [Full Text] [Related]  

  • 5. Double dose of 5-aminolevulinic acid and its effect on protoporphyrin IX accumulation in low-grade glioma.
    Suero Molina E; Black D; Kaneko S; Müther M; Stummer W
    J Neurosurg; 2022 Feb; ():1-10. PubMed ID: 35213830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-ALA in Suspected Low-Grade Gliomas: Current Role, Limitations, and New Approaches.
    Kiesel B; Freund J; Reichert D; Wadiura L; Erkkilae MT; Woehrer A; Hervey-Jumper S; Berger MS; Widhalm G
    Front Oncol; 2021; 11():699301. PubMed ID: 34395266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Corticosteroids and Antiepileptic Drugs on Visible 5-Aminolevulinic Acid Fluorescence in a Series of Initially Suspected Low-Grade Gliomas Including World Health Organization Grade II, III, and IV Gliomas.
    Wadiura LI; Mischkulnig M; Hosmann A; Borkovec M; Kiesel B; Rötzer T; Mercea PA; Furtner J; Hervey-Jumper S; Rössler K; Berger MS; Widhalm G
    World Neurosurg; 2020 May; 137():e437-e446. PubMed ID: 32045726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancement.
    Widhalm G; Kiesel B; Woehrer A; Traub-Weidinger T; Preusser M; Marosi C; Prayer D; Hainfellner JA; Knosp E; Wolfsberger S
    PLoS One; 2013; 8(10):e76988. PubMed ID: 24204718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
    Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
    J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34 microvascularity in low-grade glioma: correlation with 5-aminolevulinic acid fluorescence and patient prognosis in a multicenter study at three specialized centers.
    Hosmann A; Jaber M; Roetzer-Pejrimovsky T; Timelthaler G; Borkovec M; Kiesel B; Wadiura LI; Millesi M; Mercea PA; Phillips J; Hervey-Jumper S; Berghoff AS; Hainfellner JA; Berger MS; Stummer W; Widhalm G
    J Neurosurg; 2023 May; 138(5):1281-1290. PubMed ID: 36115057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement.
    Widhalm G; Wolfsberger S; Minchev G; Woehrer A; Krssak M; Czech T; Prayer D; Asenbaum S; Hainfellner JA; Knosp E
    Cancer; 2010 Mar; 116(6):1545-52. PubMed ID: 20108311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving contrast enhancement in magnetic resonance imaging using 5-aminolevulinic acid-induced protoporphyrin IX for high-grade gliomas.
    Yamamoto J; Kakeda S; Yoneda T; Ogura SI; Shimajiri S; Tanaka T; Korogi Y; Nishizawa S
    Oncol Lett; 2017 Mar; 13(3):1269-1275. PubMed ID: 28454245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence-Based Measurement of Real-Time Kinetics of Protoporphyrin IX After 5-Aminolevulinic Acid Administration in Human In Situ Malignant Gliomas.
    Kaneko S; Suero Molina E; Ewelt C; Warneke N; Stummer W
    Neurosurgery; 2019 Oct; 85(4):E739-E746. PubMed ID: 31058995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex-vivo analysis of quantitative 5-ALA fluorescence intensity in diffusely infiltrating gliomas using a handheld spectroscopic probe: Correlation with histopathology, proliferation and microvascular density.
    Martínez-Moreno M; Kiesel B; Woehrer A; Mischkulnig M; Furtner J; Timelthaler G; Berger W; Knosp E; Hainfellner JA; Wolfsberger S; Widhalm G
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():354-361. PubMed ID: 31102691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study.
    Schupper AJ; Baron RB; Cheung W; Rodriguez J; Kalkanis SN; Chohan MO; Andersen BJ; Chamoun R; Nahed BV; Zacharia BE; Kennedy J; Moulding HD; Zucker L; Chicoine MR; Olson JJ; Jensen RL; Sherman JH; Zhang X; Price G; Fowkes M; Germano IM; Carter BS; Hadjipanayis CG; Yong RL
    J Neurosurg; 2022 Jun; 136(6):1525-1534. PubMed ID: 34624862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence in meningioma: qualitative and quantitative measurements in vivo.
    Valdes PA; Bekelis K; Harris BT; Wilson BC; Leblond F; Kim A; Simmons NE; Erkmen K; Paulsen KD; Roberts DW
    Neurosurgery; 2014 Mar; 10 Suppl 1(0 1):74-82; discussion 82-3. PubMed ID: 23887194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors.
    Millesi M; Kiesel B; Woehrer A; Hainfellner JA; Novak K; Martínez-Moreno M; Wolfsberger S; Knosp E; Widhalm G
    Neurosurg Focus; 2014 Feb; 36(2):E11. PubMed ID: 24484249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Visible Aminolevulinic Acid-Induced Fluorescence an Independent Biomarker for Prognosis in Histologically Confirmed (World Health Organization 2016) Low-Grade Gliomas?
    Jaber M; Ewelt C; Wölfer J; Brokinkel B; Thomas C; Hasselblatt M; Grauer O; Stummer W
    Neurosurgery; 2019 Jun; 84(6):1214-1224. PubMed ID: 30107580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker.
    Valdés PA; Leblond F; Kim A; Harris BT; Wilson BC; Fan X; Tosteson TD; Hartov A; Ji S; Erkmen K; Simmons NE; Paulsen KD; Roberts DW
    J Neurosurg; 2011 Jul; 115(1):11-7. PubMed ID: 21438658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers.
    Hosmann A; Millesi M; Wadiura LI; Kiesel B; Mercea PA; Mischkulnig M; Borkovec M; Furtner J; Roetzer T; Wolfsberger S; Phillips JJ; Berghoff AS; Hervey-Jumper S; Berger MS; Widhalm G
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34064222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.